CLEC18 Suppressed by ER Stress in Chronic Hepatitis B Virus Infection and Signals an Immune Recovery Biomarker After Seroconversion
Immunity, Inflammation and Disease · 2026-11 · 14 (11)
DOI: 10.1002/iid3.70563 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, online erschienen am 17.11.2026. Verfasst von Jye‐Lin Hsu und 3 weiteren Autor:innen. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Technology.
Abstract (Originalsprache)
Background
CLEC18 is a novel C‐type lectin highly expressed in the liver and localized to the endoplasmic reticulum (ER). The previous study showed that plasma CLEC18 levels are reduced in patients with chronic hepatitis B virus (HBV) infection and are associated with treatment response to nucleos(t)ide analog (NUC) therapy. HBV is known to induce ER stress to facilitate viral replication and subvert host immune responses; However, the mechanism by which ER stress contributes to CLEC18 downregulation and impaired secretion remains unclear. Materials and Methods We retrospectively analyzed 121 patients across different clinical phases of chronic HBV infection and 17 healthy controls. Plasma CLEC18 levels were measured and compared among HBV phases. In parallel, Huh7 hepatoma cells were transfected with HBV plasmids, and ER stress was induced using tunicamycin and thapsigargin to assess unfolded protein response activation and intracellular versus extracellular CLEC18 levels.
Results
Plasma CLEC18 levels were significantly higher during the immune‐clearance phase and after hepatitis B surface antigen (HBsAg) seroconversion than in the immune‐tolerance phase. In Huh7 cells, HBV transfection or chemical induction of ER stress activated phospho‐eIF2α, ATF4, and XBP‐1 s and led to intracellular accumulation of CLEC18 with a concomitant reduction in its secretion into the supernatant.
Discussion
Chronic HBV infection appears to suppress circulating CLEC18 by ER stress–mediated impairment of its secretion, while restoration of viral control is accompanied by recovery of plasma CLEC18. CLEC18 may thus serve as a biomarker of immune recovery in chronic HBV infection, and targeting ER stress to restore CLEC18 trafficking could be a potential therapeutic approach.
Förderung
- Ministry of Science and Technology
Zitieren
APA
Hsu, J., Tsai, T., Hsieh, S., & Peng, C. (2026). CLEC18 Suppressed by ER Stress in Chronic Hepatitis B Virus Infection and Signals an Immune Recovery Biomarker After Seroconversion. Immunity, Inflammation and Disease, 14(11). https://doi.org/10.1002/iid3.70563
Vancouver
Hsu J, Tsai T, Hsieh S, Peng C. CLEC18 Suppressed by ER Stress in Chronic Hepatitis B Virus Infection and Signals an Immune Recovery Biomarker After Seroconversion. Immunity, Inflammation and Disease. 2026;14(11). doi:10.1002/iid3.70563
BibTeX
@article{Hsu2026,
author = {Hsu, Jye‐Lin and Tsai, Tsung‐Yu and Hsieh, Shie‐Liang and Peng, Cheng‐Yuan},
title = {CLEC18 Suppressed by ER Stress in Chronic Hepatitis B Virus Infection and Signals an Immune Recovery Biomarker After Seroconversion},
journal = {Immunity, Inflammation and Disease},
year = {2026},
volume = {14},
number = {11},
doi = {10.1002/iid3.70563}
}
EUVIMED